We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where aTyr Pharma, Inc. (NASDAQ:ATYR) stands against other hot biotech stocks under $5.

As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news. Investors clearly took the latter more to heart ...

These expense ratios often apply to smaller pharma, biotech, and medtech companies as well. It’s a huge investment. Yet the spend can be poorly targeted. Sales reps, despite costing well over $ ...

The pharma and biotech industry is changing rapidly — from treatment innovations to the financial ecosystem — and it’s important for leaders in the space to keep their finger on the pulse.

That is essentially the idea behind Roivant ROIV-0.64%decrease; red down pointing triangle, a biotech company with a handful of drugs it got from pharma’s dustbin. Roivant was founded by the ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds across Big Pharma skyrocketed by 281%. In 2024, Fierce Biotech reported 192 ...

By Michael Levenson 23andMe, the genetic testing company that was once valued at $6 billion but filed for bankruptcy in March, will be bought by Regeneron Pharmaceuticals, a biotechnology company ...

Competitive pressures, patent news, and mergers and acquisitions also factor into the complex dynamics of biotech stock volatility. Tonix Pharmaceuticals' stock price surged 32.48% on March 24 ...

At the Financial Times’ Global Pharma and Biotech Summit 2024, Christophe Weber, president and CEO, Takeda, discusses how trust and collaboration between the biopharma industry and stakeholders can be ...

Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 million IPO. The China-based biotech was formed in 2018 by Ascendis ...